- Home
- NNOX vs HRTX Comparison
NNOX vs HRTX Comparison
Compare NNOX & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNOX | HRTX |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.6M | 61.2M |
| IPO Year | 2019 | 2007 |
Fundamental Metrics
Financial Performance| Metric | NNOX | HRTX |
|---|---|---|
| Price | $0.70 | $0.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $5.00 | $4.50 |
| AVG Volume (30 Days) | 1.3M | ★ 2.0M |
| Earning Date | 04-20-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $154,904,000.00 |
| Revenue This Year | $147.55 | $15.28 |
| Revenue Next Year | $81.13 | $20.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $0.67 | $0.26 |
| 52 Week High | $4.71 | $1.58 |
Technical Indicators
Market Signals| Indicator | NNOX | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 41.32 | N/A |
| Support Level | $0.70 | N/A |
| Resistance Level | $1.16 | N/A |
| Average True Range (ATR) | 0.07 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 21.61 | 0.00 |
Price Performance
Historical ComparisonAbout NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.